Login / Signup

Effects of canagliflozin on total heart failure events across the kidney function spectrum: Participant-level pooled analysis from the CANVAS Program and CREDENCE trial.

Muthiah VaduganathanChristopher P CannonMeg J JardineHiddo J L HeerspinkClare ArnottBrendon L NeuenAshish SarrajuJagadish GogateJochen SeufertBruce NealVlado PerkovicKenneth W MahaffeyMikhail Naum Kosiborod
Published in: European journal of heart failure (2024)
ClinicalTrials.gov Identifier: CANVAS (NCT01032629), CANVAS-R (NCT01989754), CREDENCE (NCT02065791).
Keyphrases
  • heart failure
  • study protocol
  • clinical trial
  • phase iii
  • phase ii
  • left ventricular
  • atrial fibrillation
  • randomized controlled trial
  • acute heart failure
  • cardiac resynchronization therapy
  • open label